CareDx, Inc. (CDNA)
49.79
-2.57
(-4.91%)
USD |
NASDAQ |
Aug 28, 16:00
49.65
-0.14
(-0.28%)
After-Hours: 20:00
CareDx Free Cash Flow : 84.03M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 84.03M |
| March 31, 2026 | 64.17M |
| December 31, 2025 | 35.44M |
| September 30, 2025 | 36.42M |
| June 30, 2025 | 11.88M |
| March 31, 2025 | 20.15M |
| December 31, 2024 | 31.56M |
| September 30, 2024 | 1.222M |
| June 30, 2024 | -22.31M |
| March 31, 2024 | -42.33M |
| December 31, 2023 | -27.63M |
| September 30, 2023 | -13.74M |
| June 30, 2023 | -13.98M |
| March 31, 2023 | -21.64M |
| December 31, 2022 | -49.57M |
| September 30, 2022 | -55.16M |
| June 30, 2022 | -45.48M |
| March 31, 2022 | -33.50M |
| December 31, 2021 | -39.55M |
| September 30, 2021 | -31.13M |
| June 30, 2021 | -26.92M |
| March 31, 2021 | -8.25M |
| December 31, 2020 | 23.07M |
| September 30, 2020 | 14.02M |
| Date | Value |
|---|---|
| June 30, 2020 | 13.22M |
| March 31, 2020 | -3.343M |
| December 31, 2019 | -4.994M |
| September 30, 2019 | -1.642M |
| June 30, 2019 | -2.029M |
| March 31, 2019 | -13.07M |
| December 31, 2018 | -11.24M |
| September 30, 2018 | -14.52M |
| June 30, 2018 | -16.53M |
| March 31, 2018 | -12.26M |
| December 31, 2017 | -14.49M |
| September 30, 2017 | -15.24M |
| June 30, 2017 | -14.57M |
| March 31, 2017 | -17.58M |
| December 31, 2016 | -17.07M |
| September 30, 2016 | -18.14M |
| June 30, 2016 | -20.01M |
| March 31, 2016 | -15.87M |
| December 31, 2015 | -10.95M |
| September 30, 2015 | -8.021M |
| June 30, 2015 | -8.432M |
| March 31, 2015 | -5.622M |
| December 31, 2014 | -4.083M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Natera, Inc. | 51.20M |
| Caris Life Sciences, Inc. | 116.25M |
| Myriad Genetics, Inc. | -14.20M |
| BioRestorative Therapies, Inc. | -11.90M |
| Exagen, Inc. | -7.588M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 30.60M |
| Cash from Investing (Quarterly) | 280.59M |
| Cash from Financing (Quarterly) | -15.50M |
| Free Cash Flow Per Share (Quarterly) | 0.5381 |
| Free Cash Flow to Equity (Quarterly) | 34.00M |
| Free Cash Flow to Firm (Quarterly) | 28.75M |
| Free Cash Flow Yield | 3.19% |